55 North, the world’s largest dedicated quantum technology venture capital fund, has announced the first close of its €300 million Fund I at €134 million, marking a significant milestone for both the European and global quantum ecosystems. The fund establishes…
Genialis, the RNA biomarker company, announced a new collaboration with Cleveland Clinic, one of the world’s leading academic medical centers, to co-develop AI-driven tools that aim to personalize treatment for patients with pancreatic ductal adenocarcinoma (PDAC)—the most prevalent and deadliest…
Thermo Fisher Scientific and AstraZeneca BioVentureHub Announce Strategic R&D Partnership to Advance Life Science Innovation. The PPD™ clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, today announced a new research and development (R&D) partnership…
PINC Technologies, a Caltech spinout developing advanced integrated nonlinear photonic devices and circuits, announced the close of its Seed+ financing round, bringing total funds raised to date to $6.8 million. The funding marks a major milestone for the young company…
CytoAgents, Inc., a clinical-stage biotechnology company focused on developing safe and effective preventative therapies for life-threatening immune-related toxicities, today announced it has been awarded a $2.25 million grant from the National Institutes of Health (NIH). This grant, issued through the…
Predicta Biosciences, a precision oncology company pioneering next-generation diagnostic and therapeutic discovery solutions, today announced the successful close of a $23.4 million oversubscribed Series A financing round. The investment was led by Engine Ventures, with strong participation from Illumina Ventures,…